Increased resistin blood levels are not associated with insulin resistance in patients with renal disease

American Journal of Kidney Diseases

Volumn 42, Issue 1 SUPPL. 2, 2003, Pages 62-66

  Kielstein, Jan T ^b   Becker, Björn ^b   Graf, Susanne ^b   Brabant, Georg ^b   Haller, Hermann ^b   Fliser, Danilo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Glomerular filtration rate (GFR); Insulin resistance; Renal disease; Resistin; Uremia

Indexed keywords

HOMOCYSTEINE; INSULIN; RESISTIN;

ADIPOCYTE; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; GLOMERULUS FILTRATION RATE; GLUCOSE TOLERANCE TEST; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INULIN CLEARANCE; KIDNEY DISEASE; KIDNEY FAILURE; MALE; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL;

EID: 0038048074     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00409-8     Document Type: Article

References (20)

1. DeFronzo RA, Alverstrand A, Smith D, Hendler R, Hendler E, Wahren J: Insulin resistance in uremia. J Clin Invest 67:563-572, 1981
2. Kautzky-Willer A, Pacini G, Barnas U, et al: Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 47:200-206, 1995
3. Alvestrand A: Carbohydrate and insulin metabolism in renal failure. Kidney Int Suppl 52:S48-S52, 1997
4. Eidemak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, Strandgaard S: Insulin resistance and hyper-insulinemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 38:565-572, 1995
5. Vareesangthip K, Tong P, Wilkinson R, Thomas TH: Insulin resistance in adult polycystic kidney disease. Kidney Int 52:503-508, 1997
6. Fliser D, Pacini G, Engelleiter R, et al: Insulin resistance and hyperinsulinaemia are present already in patients with incipient renal disease. Kidney Int 53:1243-1247, 1998
7. Kato Y, Hayashi M, Ohno Y, Suzawa T, Sasaki T, Saruta T: Mild renal dysfunction is associated with insulin resistance in chronic glomerulonephritis. Clin Nephrol 54: 366-373, 2000
8. Wirthensohn G, Guder WG: Renal substrate metabolism. Physiol Rev 66:469-497, 1986
9. Stumvoll M, Chintalapudi U, Perriello G, Welle S, Gutierrez O, Gerich J: Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. J Clin Invest 96:2528-2533, 1995
10. Cersosimo E, Garlick P, Ferretti J: Insulin regulation of renal glucose metabolism in humans. Am J Physiol 276:E78-E84, 1999
11. Meyer C, Stumvoll M, Dostou J, Welle S, Haymond M, Gerich J: Renal substrate exchange and gluconeogenesis in normal postabsorptive humans. Am J Physiol 282:E428-E434, 2002
12. Steppan CM, Bailey ST, Bhat S, et al: The hormone resistin links obesity to diabetes. Nature 409:307-312, 2001
13. Ma X, Warram JH, Trischitta V, Doria A: Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87:4407-4410, 2002
14. Bergman RN: Toward physiological understanding of glucose tolerance: Minimal-model approach. Diabetes 38: 1512-1527, 1989
15. Fliser D, Zeier M, Nowack R, Ritz E: Renal functional reserve in healthy elderly people. J Am Soc Nephrol 3:1371-1377, 1993
16. Pacini G, Bergman RN: MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsitivity from the frequently sampled intravenous glucose tolerance test. Comp Methods Progr Biomed 23:113-122, 1986
17. Hegele RA, Kraw ME, Ban MR, Miskie BA, Huff MW, Cao H: Elevated serum CRP and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial dystrophy. Arterioscler Thromb Vasc Biol 23:111-116, 2003
18. Bostom AG, Culleton BF: Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 10:891-900, 1999
19. Nagaev I, Smith U: Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285:561-564, 2001
20. Savage DB, Sewter CP, Klenk ES, et al: Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50:2199-2202, 2001